Title : The feasibility of 18F-FES and 18F-FDG microPET/CT for early monitoring the effect of fulvestrant on sensitizing docetaxel by downregulating ERα in ERα+ breast cancer.

Pub. Date : 2018 May

PMID : 29478216






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 OBJECTIVE: Our study aimed to investigate the feasibility of PET/CT for monitoring the influence of fulvestrant on sensitizing docetaxel by downregulating ERalpha in ERalpha+ breast cancer. Docetaxel estrogen receptor 1 (alpha) Mus musculus
2 OBJECTIVE: Our study aimed to investigate the feasibility of PET/CT for monitoring the influence of fulvestrant on sensitizing docetaxel by downregulating ERalpha in ERalpha+ breast cancer. Docetaxel estrogen receptor 1 (alpha) Mus musculus
3 RESULTS: ERalpha expression level and growth rate of DIS-ZR751 were higher than control group and decreased dramatically after docetaxel and fulvestrant combination treatment. Docetaxel estrogen receptor 1 (alpha) Mus musculus